See the DrugPatentWatch profile for Ezetimibe
Ezetimibe, an intestinal cholesterol absorption inhibitor, is protected by several patents. DrugPatentWatch.com tracks these patents, providing insights into their expiration dates and potential challenges [1].
When does the Ezetimibe patent expire?
The primary patents for ezetimibe have expired, allowing for the potential market entry of generic versions. However, the exact expiry dates can vary depending on specific patent filings and any subsequent legal challenges or extensions [1].
What are the key patents protecting Ezetimibe?
Ezetimibe's development and sale have been associated with various patents covering its composition of matter, manufacturing processes, and therapeutic uses. These patents were crucial for establishing market exclusivity for the innovator drug [1].
Can generic versions of Ezetimibe be sold?
With the expiration of key patents, generic versions of ezetimibe can be manufactured and sold. This typically leads to increased competition and lower prices for consumers [1].
What is the status of Ezetimibe patent litigation?
Patent litigation is common in the pharmaceutical industry, and ezetimibe has likely been subject to such disputes. Legal challenges can impact the timeline for generic market entry and the duration of market exclusivity for the innovator product [1].
How does Ezetimibe compare to other cholesterol-lowering drugs?
Ezetimibe works by reducing the absorption of cholesterol in the small intestine, a mechanism distinct from statins, which inhibit cholesterol production in the liver. It is often prescribed alone or in combination with statins to achieve greater reductions in LDL cholesterol [2].
Who are the main manufacturers of Ezetimibe?
The original developer of ezetimibe was Merck & Co. Following patent expiries, numerous generic pharmaceutical companies have entered the market, producing their own versions of the drug [1].
What are the clinical uses and benefits of Ezetimibe?
Ezetimibe is used to lower elevated total cholesterol, LDL cholesterol, apolipoprotein B (apo B), and triglycerides in patients with hypercholesterolemia. It is also used in combination with diet to reduce total cholesterol, LDL cholesterol, and apo B in patients with homozygous familial hypercholesterolemia [3].
What are the potential side effects of Ezetimibe?
Common side effects associated with ezetimibe include diarrhea, fatigue, joint pain, and upper respiratory tract infection. More serious, though less common, side effects can also occur [4].
Sources:
1. https://drugpatentwatch.com/
2. https://www.ncbi.nlm.nih.gov/books/NBK547799/
3. https://www.rxlist.com/ezetimibe-monograph.htm
4. https://www.mayoclinic.org/drugs-supplements/ezetimibe-oral-route/side-effects/drg-20064676